02105nam a2200445 i 4500 279807 279807 on1086389949 OCoLC 20190318103535.0 m o d f cr gn||||||||| 190220s2019 dcua ob f000 0 eng c PUCPR eng rda pn GPO MvI pcc n-us--- 1019-C-01 (online) Y 4.C 73/8:115-96 Serial no. 115-96 (United States. Congress. House. Committee on Energy and Commerce) Y 4.C 73/8:115-96 United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018. Washington : U.S. Government Publishing Office, 2019. 1 online resource (vi, 286 pages) : illustrations txt c rdamedia cr rdacarrier "Serial no. 115-96." CRDP Program record. Includes bibliographical references. Description based on online resource; title from PDF title page (govinfo, viewed Feb. 20, 2019). Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining implementation of the Compounding Quality Act (OCoLC)1085900766 https://purl.fdlp.gov/GPO/gpo116408 KF27 .E553 2018e United States. Drug Quality and Security Act. United States. Food and Drug Administration Rules and practice. Drugs Dosage forms Government policy United States. Pharmaceutical industry Government policy United States. Drug adulteration United States Prevention. Legislative hearings. lcgft sudocs 8 0 0 sudocs 0 Y_4C_73811596 0 406863 7 7 55 2019-03-18 0 Y 4.C 73/8:115-96 Y 4.C 73/8:115-96 2019-03-18 00:00:00 1 2019-03-18 8